Alzchem Group new partner of FC Bayern Basketball Munich, November 12, 2024 – FC Bayern Basketball and Alzchem, a company based in Trostberg, have joined forces for the new season to achieve success together. With Alzchem's premium brand Creapure®, the internationally renowned manufacturer of creatine monohydrate will accompany the German champions on their way through the coming season as an official gold partner. Creapure® stands for the highest purity and quality in the field of sports nutrition and is recognized by athletes worldwide. As the leading and only Western manufacturer of creatine, Alzchem places particular emphasis on “made in Germany” production and innovative technologies. The partnership with FC Bayern Basketball marks a further milestone in the combination of top athletic performance and high-quality nutrition. “We are pleased to have Creapure® at our side as a partner,” says Adrian Sarmiento, Chief Strategy Officer of FCBB. ”With a reliable partner like Creapure®, we are committed to the highest quality and support the team's performance.” The collaboration includes not only direct support for the two-time champions during the season in the EuroLeague and BBL, but also joint marketing and communication measures to emphasize the importance of sports nutrition and performance enhancement. Creapure® will be visible in the communication in the BMW Park, in the new SAP Garden and on the social media channels of FCBB, offering fans important insights into the world of sports nutrition. “FC Bayern Basketball stands for success, commitment and team spirit – values that Creapure® also embodies,” explains Andreas Niedermaier, CEO of the Alzchem Group. ”We are proud to support the team with creatine of the highest quality and look forward to a successful season.” About Creapure® About FC Bayern Basketball About Alzchem The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments. The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023. End of Media Release Issuer: Alzchem Group AG Key word(s): Sports
12.11.2024 CET/CEST Dissemination of a Press Release, transmitted by EQS News - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Indices: | SDAX |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 2027527 |
End of News | EQS Media |
|
2027527 12.11.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.